← Back to the feed

Brame AG

History from 28 May 2019

UID

CHE-198.627.482

Legal form

AG

Canton

SZ

Founded

28 May 2019

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 10 Nov 2021 · legal date 25 Oct 2021

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   109’374.50 → 114’452.70

   Shares

   1’093’745 → 1’144’527

   New shares, % of post-step shares

   4.4% (50’782 new)

   Aktienkapital neu: CHF 114'452.70 [bisher: CHF 109'374.50]. Liberierung Aktienkapital neu: CHF 114'452.70 [bisher: CHF 109'374.50]. Aktien neu: 1'144'527 Namenaktien zu CHF 0.10 [bisher: 1'093'745 Namenaktien zu CHF 0.10]. Genehmigte Kapitalerhöhung [gestützt auf den Ermächtigungsbeschluss vom 09.02.2021].

   SHAB HR02-1005330710 ↗

2. SHAB published 3 Jun 2022 · legal date 25 May 2022

   Capital increase

   Not assessed

   Paid in cash and by other means

   Nominal capital

   114’452.70 → 136’222.30

   Shares

   1’144’527 → 1’362’223

   New shares, % of post-step shares

   16.0% (217’696 new)

   Aktienkapital neu: CHF 136'222.30 [bisher: CHF 114'452.70]. Liberierung Aktienkapital neu: CHF 136'222.30 [bisher: CHF 114'452.70]. Aktien neu: 1'362'223 Namenaktien zu CHF 0.10 [bisher: 1'144'527 Namenaktien zu CHF 0.10]. [gestrichen: Die Gesellschaft hat mit Beschluss vom 09.02.2021 eine genehmigte Kapitalerhöhung gemäss näherer Umschreibung in Art. 3b der Statuten beschlossen.]. Die Gesellschaft hat mit Beschluss vom 25.05.2022 die mit Beschluss vom 09.02.2021 eingeführte genehmigte Kapitalerhöhung gemäss näherer Umschreibung in Art. 3b der Statuten geändert. Genehmigte Kapitalerhöhung [Ermächtigungsbeschluss vom 09.02.2021].

   SHAB HR02-1005487780 ↗

3. SHAB published 20 Sep 2022 · legal date 6 Sep 2022

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   136’222.30 → 137’598.30

   Shares

   1’362’223 → 1’375’983

   New shares, % of post-step shares

   1.0% (13’760 new)

   Aktienkapital neu: CHF 137'598.30 [bisher: CHF 136'222.30]. Liberierung Aktienkapital neu: CHF 137'598.30 [bisher: CHF 136'222.30]. Aktien neu: 1'375'983 Namenaktien zu CHF 0.10 [bisher: 1'362'223 Namenaktien zu CHF 0.10]. Genehmigte Kapitalerhöhung [Ermächtigungsbeschluss vom 25.05.2022].

   SHAB HR02-1005564952 ↗

4. SHAB published 7 Jun 2023 · legal date 26 May 2023

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   137’598.30 → 154’736.10

   Shares

   1’375’983 → 1’547’361

   New shares, % of post-step shares

   11.1% (171’378 new)

   Aktienkapital neu: CHF 154'736.10 [bisher: CHF 137'598.30]. Liberierung Aktienkapital neu: CHF 154'736.10 [bisher: CHF 137'598.30]. Aktien neu: 1'547'361 Namenaktien zu CHF 0.10 [bisher: 1'375'983 Namenaktien zu CHF 0.10]. Genehmigte Kapitalerhöhung [Ermächtigungsbeschluss vom 25.05.2022].

   SHAB HR02-1005762452 ↗

5. SHAB published 12 Jan 2024 · legal date 21 Dec 2023

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   154’736.10 → 167’944.70

   Shares

   1’547’361 → 1’679’447

   New shares, % of post-step shares

   7.9% (132’086 new)

   Aktienkapital neu: CHF 167'944.70 [bisher: CHF 154'736.10]. Liberierung Aktienkapital neu: CHF 167'944.70 [bisher: CHF 154'736.10]. Aktien neu: 1'679'447 Namenaktien zu CHF 0.10 [bisher: 1'547'361 Namenaktien zu CHF 0.10]. Genehmigte Kapitalerhöhung [Ermächtigungsbeschluss vom 25.05.2022]. [gestrichen: Die Gesellschaft hat mit Beschluss vom 25.05.2022 die mit Beschluss vom 09.02.2021 eingeführte genehmigte Kapitalerhöhung gemäss näherer Umschreibung in Art. 3b der Statuten geändert.]. Kapitalband gemäss näherer Umschreibung in Art. 3b der Statuten.

   SHAB HR02-1005932736 ↗

6. SHAB published 12 Jan 2024 · legal date 21 Dec 2023

   Capital band adopted

   SHAB HR02-1005932736 ↗

7. SHAB published 22 Oct 2024 · legal date 30 Sep 2024

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   167’944.70 → 186’129.50

   Shares

   1’679’447 → 1’861’295

   New shares, % of post-step shares

   9.8% (181’848 new)

   Aktienkapital neu: CHF 186'129.50 [bisher: CHF 167'944.70]. Liberierung Aktienkapital neu: CHF 186'129.50 [bisher: CHF 167'944.70]. Aktien neu: 1'861'295 Namenaktien zu CHF 0.10 [bisher: 1'679'447 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbands.

   SHAB HR02-1006159763 ↗

8. SHAB published 6 May 2025 · legal date 22 Apr 2025

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   186’129.50 → 205’444.70

   Shares

   1’861’295 → 2’054’447

   New shares, % of post-step shares

   9.4% (193’152 new)

   Aktienkapital neu: CHF 205'444.70 [bisher: CHF 186'129.50]. Liberierung Aktienkapital neu: CHF 205'444.70 [bisher: CHF 186'129.50]. Aktien neu: 2'054'447 Namenaktien zu CHF 0.10 [bisher: 1'861'295 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbands.

   SHAB HR02-1006324615 ↗

9. SHAB published 17 Oct 2025 · legal date 8 Oct 2025

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   205’444.70 → 236’258.20

   Shares

   2’054’447 → 2’362’582

   New shares, % of post-step shares

   13.0% (308’135 new)

   Aktienkapital neu: CHF 236'258.20 [bisher: CHF 205'444.70]. Liberierung Aktienkapital neu: CHF 236'258.20 [bisher: CHF 205'444.70]. Aktien neu: 2'362'582 Namenaktien zu CHF 0.10 [bisher: 2'054'447 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbands.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.68 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006460808 ↗

10. SHAB published 3 Dec 2025 · legal date 20 Nov 2025

    Capital increase

    ◐○○Capital increased · undecided

    Paid in cash

    Nominal capital

    236’258.20 → 247’761.90

    Shares

    2’362’582 → 2’477’619

    New shares, % of post-step shares

    4.6% (115’037 new)

    Aktienkapital neu: CHF 247'761.90 [bisher: CHF 236'258.20]. Liberierung Aktienkapital neu: CHF 247'761.90 [bisher: CHF 236'258.20]. Aktien neu: 2'477'619 Namenaktien zu CHF 0.10 [bisher: 2'362'582 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbands.

    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.45 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006501404 ↗

11. SHAB published 19 Feb 2026 · legal date 11 Feb 2026

    Capital increase

    ◐○○Capital increased · undecided

    Paid in cash

    Nominal capital

    247’761.90 → 254’630.10

    Shares

    2’477’619 → 2’546’301

    New shares, % of post-step shares

    2.7% (68’682 new)

    Aktienkapital neu: CHF 254'630.10 [bisher: CHF 247'761.90]. Liberierung Aktienkapital neu: CHF 254'630.10 [bisher: CHF 247'761.90]. Aktien neu: 2'546'301 Namenaktien zu CHF 0.10 [bisher: 2'477'619 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbands.

    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.42 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006574158 ↗

12. SHAB published 17 Sep 2026 · legal date 22 Jul 2026

    Capital increase

    ◐○○Capital increased · undecided

    Paid in cash

    Nominal capital

    254’630.10 → 267’369

    Shares

    2’546’301 → 2’673’690

    New shares, % of post-step shares

    4.8% (127’389 new)

    Aktienkapital neu: CHF 267'369.00 [bisher: CHF 254'630.10]. Liberierung Aktienkapital neu: CHF 267'369.00 [bisher: CHF 254'630.10]. Aktien neu: 2'673'690 Namenaktien zu CHF 0.10 [bisher: 2'546'301 Namenaktien zu CHF 0.10]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbands.

    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.40 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006758683 ↗

Published by 8 Oct 2026